PSI Webinar: Master protocols - theory, application and regulatory considerations
For this webinar, PSI brings together experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies.
Our award for statistical excellence in the pharmaceutical industry is made jointly with the RSS (Royal Statistical Society) every year. The award is for the most influential example of the application of an existing statistical practice, or the implementation of an innovative statistical practice, in this industry.
We are looking for entries that have demonstrated one or more of the following:
Nominees can be based anywhere in the world and do not need to be a member of PSI or the RSS. Updates on where and when the Award will be presented will be posted in due course.
The deadline for entries is midnight on Friday 22nd May 2020.
The 2019 award was jointly presented to Mike Smith (Pfizer) for his work on ‘Excellence in research around population modelling in drug development’ and its ‘pioneering practical Bayesian methods with drug development in the context of optimising decision making within trials and modelling dose response with pharmacokinetic/pharmacodynamic modelling’ and Graeme Archer and Jacquie Christie (GSK) for their work on ‘Quantitative Decision-Making for clinical development’, which was deemed to be ‘at the cutting edge of revolutionising data driven decision making within the industry’.
The 2018 award was jointly presented to Dr. Mouna Akacha (Novartis) for “Enhancing drug development using clinically interpretable treatment effect measures (‘estimands‘) that allow for efficient statistical analyses” and Dr. Simon Bate for “Improving the quality and reliability of animal research through the use of InVivoStat: a statistical software package for animal researchers”.
The 2017 award was presented to Michael O'Kelly for his work 'Promoting analytical solutions and best practices for handling missing data in pharmaceutical industry'. The judges felt that in this respect, he has made a major contribution to enhancing the practical application of modelling and simulation methodology and tools for analysing data with missing values.
Richard Nixon of Novartis was presented with the award in 2016 for “Enhancing decision-making in drug development using quantitative approaches’.
Katrina Gore and Nicky Best (joint winners, 2015, Pfizer and GSK respectively). Katrina Gore for her work on the Assay Capability Tool (ACT), designed to guide the development of drug discovery assays. Nicky Best for her work implementing a process that has turned beliefs about the chances of success into formal prior distributions.